Literature DB >> 20545384

A diagnostic interview module for anabolic-androgenic steroid dependence: preliminary evidence of reliability and validity.

Harrison G Pope1, Joseph Kean, Adam Nash, Gen Kanayama, Douglas B Samuel, Warren K Bickel, James I Hudson.   

Abstract

The syndrome of anabolic-androgenic steroid (AAS) dependence, though well recognized, remains poorly studied. In this preliminary psychometric study, American and British investigators separately administered a structured diagnostic interview module, based on recently proposed criteria for AAS dependence, to 42 male AAS users in Middlesbrough, England. Another investigator, blinded to the diagnostic interview findings, assessed self-reported symptoms of "muscle-dysmorphia"; effects of AAS on various aspects of functioning; and maximum proportion of annual income spent on AAS. We also assessed demographic measures, history of other substance use, and performance on a hypothetical AAS-purchasing task. The interview module yielded very good interrater reliability (kappa = 0.76 and overall intraclass correlation = 0.79) and strong internal consistency (Cronbach's alpha = 0.77-0.87). Men diagnosed as AAS-dependent, when compared to nondependent men, reported significantly earlier onset of AAS use, longer duration and higher maximum doses of AAS used, more frequent use of other performance-enhancing drugs, and a somewhat larger maximum percentage of income spent on AAS. Dependent users also "bought" more AAS in the hypothetical purchase task, but rated significantly more negatively the effects of AAS on their mental health-findings all suggesting that the diagnosis of AAS dependence shows construct validity. As a group, AAS users showed high preoccupation with muscular appearance, but dependence per se was not significantly associated with this measure-suggesting that the diagnosis of AAS dependence shows some evidence of discriminant validity. Collectively, these findings suggest that AAS dependence may be diagnosed reliably, with preliminary evidence for construct and discriminant validity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20545384      PMCID: PMC2913447          DOI: 10.1037/a0019370

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  49 in total

Review 1.  Deconstructing relative reinforcing efficacy and situating the measures of pharmacological reinforcement with behavioral economics: a theoretical proposal.

Authors:  W K Bickel; L A Marsch; M E Carroll
Journal:  Psychopharmacology (Berl)       Date:  2000-12       Impact factor: 4.530

2.  Modeling drug consumption in the clinic using simulation procedures: demand for heroin and cigarettes in opioid-dependent outpatients.

Authors:  E A Jacobs; W K Bickel
Journal:  Exp Clin Psychopharmacol       Date:  1999-11       Impact factor: 3.157

3.  Validity of the SCID in substance abuse patients.

Authors:  H R Kranzler; R M Kadden; T F Babor; H Tennen; B J Rounsaville
Journal:  Addiction       Date:  1996-06       Impact factor: 6.526

4.  The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability.

Authors:  J B Williams; M Gibbon; M B First; R L Spitzer; M Davies; J Borus; M J Howes; J Kane; H G Pope; B Rounsaville
Journal:  Arch Gen Psychiatry       Date:  1992-08

5.  Relative reinforcing efficacy of alcohol among college student drinkers.

Authors:  James G Murphy; James MacKillop
Journal:  Exp Clin Psychopharmacol       Date:  2006-05       Impact factor: 3.157

6.  Trends in non-medical use of anabolic steroids by U.S. college students: results from four national surveys.

Authors:  Sean Esteban McCabe; Kirk J Brower; Brady T West; Toben F Nelson; Henry Wechsler
Journal:  Drug Alcohol Depend       Date:  2007-05-23       Impact factor: 4.492

Review 7.  Substance use disorders: Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) and International Classification of Diseases, tenth edition (ICD-10).

Authors:  Deborah Hasin; Mark L Hatzenbuehler; Katherine Keyes; Elizabeth Ogburn
Journal:  Addiction       Date:  2006-09       Impact factor: 6.526

Review 8.  Treatment of anabolic-androgenic steroid dependence: Emerging evidence and its implications.

Authors:  Gen Kanayama; Kirk J Brower; Ruth I Wood; James I Hudson; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2010-02-25       Impact factor: 4.492

9.  Steroid and prescription medicine abuse in the health and fitness community: A regional study.

Authors:  J S Baker; M R Graham; B Davies
Journal:  Eur J Intern Med       Date:  2006-11       Impact factor: 4.487

10.  Youth risk behavior surveillance--United States, 2007.

Authors:  Danice K Eaton; Laura Kann; Steve Kinchen; Shari Shanklin; James Ross; Joseph Hawkins; William A Harris; Richard Lowry; Tim McManus; David Chyen; Connie Lim; Nancy D Brener; Howell Wechsler
Journal:  MMWR Surveill Summ       Date:  2008-06-06
View more
  16 in total

1.  Culture, psychosomatics and substance abuse: the example of body image drugs.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Psychother Psychosom       Date:  2012-01-18       Impact factor: 17.659

2.  Risk factors for illicit anabolic-androgenic steroid use in male weightlifters: a cross-sectional cohort study.

Authors:  Harrison G Pope; Gen Kanayama; James I Hudson
Journal:  Biol Psychiatry       Date:  2011-08-12       Impact factor: 13.382

3.  National Athletic Trainers' Association position statement: anabolic-androgenic steroids.

Authors:  Robert D Kersey; Diane L Elliot; Linn Goldberg; Gen Kanayama; James E Leone; Mike Pavlovich; Harrison G Pope
Journal:  J Athl Train       Date:  2012 Sep-Oct       Impact factor: 2.860

Review 4.  Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.

Authors:  Harrison G Pope; Ruth I Wood; Alan Rogol; Fred Nyberg; Larry Bowers; Shalender Bhasin
Journal:  Endocr Rev       Date:  2013-12-17       Impact factor: 19.871

Review 5.  Illicit use of androgens and other hormones: recent advances.

Authors:  Gen Kanayama; Harrison G Pope
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-06       Impact factor: 3.243

6.  Fitness supplements as a gateway substance for anabolic-androgenic steroid use.

Authors:  Tom Hildebrandt; Seth Harty; James W Langenbucher
Journal:  Psychol Addict Behav       Date:  2012-04-09

7.  Cognitive deficits in long-term anabolic-androgenic steroid users.

Authors:  Gen Kanayama; Joseph Kean; James I Hudson; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2012-12-14       Impact factor: 4.492

8.  The Hotel Room Purchase Task: Effects of Gender and Partner Desirability on Demand for Hypothetical Sex in Individuals with Disordered Cocaine Use and Controls.

Authors:  Sean B Dolan; Patrick S Johnson; Matthew W Johnson
Journal:  Arch Sex Behav       Date:  2020-01-27

Review 9.  Muscle dysmorphia: current insights.

Authors:  David Tod; Christian Edwards; Ieuan Cranswick
Journal:  Psychol Res Behav Manag       Date:  2016-08-03

10.  The Misuse of Anabolic-Androgenic Steroids among Iranian Recreational Male Body-Builders and Their Related Psycho-Socio-Demographic factors.

Authors:  Hooman Angoorani; Farzin Halabchi
Journal:  Iran J Public Health       Date:  2015-12       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.